IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)
August 19, 2021
August 19, 2021
August 19, 2021
July 27, 2021
July 7, 2021
June 8, 2021
February 25, 2021
February 10, 2021
December 16, 2020
December 10, 2020
November 19, 2024
Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, announced their collaboration to enhance cancer diagnostics and thus c...
November 18, 2024
Antibodies and conjugates to illuminate your research Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life s...
November 14, 2024
Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225